480 related articles for article (PubMed ID: 28536774)
41. Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.
Rasool MF; Khalil F; Läer S
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):383-396. PubMed ID: 27313074
[TBL] [Abstract][Full Text] [Related]
42. Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues.
Zake DM; Kurlovics J; Zaharenko L; Komasilovs V; Klovins J; Stalidzans E
PLoS One; 2021; 16(4):e0249594. PubMed ID: 33826656
[TBL] [Abstract][Full Text] [Related]
43. Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model.
Li J; Guo HF; Liu C; Zhong Z; Liu L; Liu XD
Clin Pharmacokinet; 2015 Feb; 54(2):179-93. PubMed ID: 25316573
[TBL] [Abstract][Full Text] [Related]
44. A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.
Ladumor MK; Thakur A; Sharma S; Rachapally A; Mishra S; Bobe P; Rao VK; Pammi P; Kangne H; Levi D; Balhara A; Ghandikota S; Joshi A; Nautiyal V; Prasad B; Singh S
Sci Rep; 2019 Jul; 9(1):9709. PubMed ID: 31273226
[TBL] [Abstract][Full Text] [Related]
45. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
[TBL] [Abstract][Full Text] [Related]
46. A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K
Lee HA; Lee KR; Jang SB; Chung SY; Yu KS; Lee H
Eur J Pharm Sci; 2019 Mar; 130():1-10. PubMed ID: 30641142
[TBL] [Abstract][Full Text] [Related]
47. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
Edginton AN; Schmitt W; Willmann S
Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
[TBL] [Abstract][Full Text] [Related]
48. Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate.
Donovan MD; Abduljalil K; Cryan JF; Boylan GB; Griffin BT
Biopharm Drug Dispos; 2018 Mar; 39(3):125-134. PubMed ID: 29319897
[TBL] [Abstract][Full Text] [Related]
49. Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug-Drug Interaction Prediction.
Chen Y; Ma F; Lu T; Budha N; Jin JY; Kenny JR; Wong H; Hop CE; Mao J
Clin Pharmacokinet; 2016 Jun; 55(6):735-49. PubMed ID: 26692192
[TBL] [Abstract][Full Text] [Related]
50. Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin.
Parrott N; Hainzl D; Alberati D; Hofmann C; Robson R; Boutouyrie B; Martin-Facklam M
Clin Pharmacokinet; 2013 Aug; 52(8):673-83. PubMed ID: 23591780
[TBL] [Abstract][Full Text] [Related]
51. Physiology-based pharmacokinetics of caspofungin for adults and paediatrics.
Stader F; Wuerthwein G; Groll AH; Vehreschild JJ; Cornely OA; Hempel G
Pharm Res; 2015 Jun; 32(6):2029-37. PubMed ID: 25522788
[TBL] [Abstract][Full Text] [Related]
52. Simulation of the Pharmacokinetics of Oseltamivir and Its Active Metabolite in Normal Populations and Patients with Hepatic Cirrhosis Using Physiologically Based Pharmacokinetic Modeling.
Chen Y; Ke M; Xu J; Lin C
AAPS PharmSciTech; 2020 Mar; 21(3):98. PubMed ID: 32128656
[TBL] [Abstract][Full Text] [Related]
53. Kidney function and age are both predictors of pharmacokinetics of metformin.
Sambol NC; Chiang J; Lin ET; Goodman AM; Liu CY; Benet LZ; Cogan MG
J Clin Pharmacol; 1995 Nov; 35(11):1094-102. PubMed ID: 8626883
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of Model-Based Prediction of Pharmacokinetics in the Renal Impairment Population.
Yee KL; Li M; Cabalu T; Sahasrabudhe V; Lin J; Zhao P; Jadhav P
J Clin Pharmacol; 2018 Mar; 58(3):364-376. PubMed ID: 29077203
[TBL] [Abstract][Full Text] [Related]
55. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S
Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128
[TBL] [Abstract][Full Text] [Related]
56. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
T'jollyn H; Vermeulen A; Van Bocxlaer J
AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
[TBL] [Abstract][Full Text] [Related]
57. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
[TBL] [Abstract][Full Text] [Related]
58. Physiologically Based Pharmacokinetic Modeling of Metformin in Children and Adolescents With Obesity.
Ford JL; Gerhart JG; Edginton AN; Yanovski JA; Hon YY; Gonzalez D
J Clin Pharmacol; 2022 Aug; 62(8):960-969. PubMed ID: 35119103
[TBL] [Abstract][Full Text] [Related]
59. Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.
Villiger A; Stillhart C; Parrott N; Kuentz M
AAPS J; 2016 Jul; 18(4):933-47. PubMed ID: 27060007
[TBL] [Abstract][Full Text] [Related]
60. Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an Example.
Feng S; Shi J; Parrott N; Hu P; Weber C; Martin-Facklam M; Saito T; Peck R
Clin Pharmacokinet; 2016 Jul; 55(7):823-832. PubMed ID: 26715215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
